Oscar Health Shares Surge 80% YTD After Barclays Boosts Price Target to $35
OSCR•Barclays upgraded Oscar Health to Overweight from Equal Weight, raising its price target to $35 and citing direct leverage to the Affordable Care Act individual market. Shares hit fresh 52-week highs, extending an 80% year-to-date gain after management reaffirmed first-quarter guidance at the Goldman Sachs Healthcare Conference.
1. Barclays Raises Price Target to $35
Barclays upgraded Oscar Health to Overweight from Equal Weight and lifted its price target from $30 to $35, highlighting the insurer’s single-line exposure to the individual Affordable Care Act market as a key driver for a potential multi-year multiple re-rating.
2. Shares Reach 52-Week Highs with 80% YTD Gain
Oscar Health stock climbed to fresh 52-week highs, pushing its year-to-date gain to 80% as investors responded to the upgrade and the company’s strong positioning in the ACA marketplace.
3. Q1 Guidance Reaffirmed at Goldman Sachs Conference
During the Goldman Sachs Healthcare Conference, Oscar Health management reaffirmed first-quarter revenue and membership targets, reinforcing investor confidence and supporting recent bullish analyst outlooks.
